Get the Stockscreener App
3.28
7.19%
0.22
Health Catalyst Inc stock is traded at $3.28, with a volume of 1.04M.
It is up +7.19% in the last 24 hours and down -16.75% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.06
Open:
$3.09
24h Volume:
1.04M
Relative Volume:
1.59
Market Cap:
$230.83M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.1867
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+12.33%
1M Performance:
-16.75%
6M Performance:
-37.28%
1Y Performance:
-53.54%
1-Day Range:
$3.08
$3.31
1-Week Range:
$2.87
$3.31
52-Week Range:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.28 | 211.12M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Healthcare Predictive Analytics Market to Witness Growth - openPR.com
Health Catalyst Inc. Nearing Breakout Level After BounceTrade Performance Summary & Weekly High Momentum Picks - beatles.ru
Is Health Catalyst Inc. stock good for income investorsEarnings Recap Report & Expert Approved Trade Ideas - classian.co.kr
Health Catalyst Inc. Sees Relief Buying After Extended Drop2025 Dividend Review & Low Drawdown Trading Strategies - beatles.ru
Can trapped investors hope for a rebound in Health Catalyst Inc.Quarterly Portfolio Review & Low Volatility Stock Suggestions - Newser
Top Risks to Consider Before Buying Health Catalyst Inc. StockMarket Risk Summary & Fast Gain Swing Alerts - Newser
XTX Topco Ltd Makes New Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - Defense World
Health Catalyst Inc. stock chart pattern explained2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Using economic indicators to assess Health Catalyst Inc. potentialRisk Management & Real-Time Chart Breakout Alerts - Newser
Risk adjusted return profile for Health Catalyst Inc. analyzedTrade Risk Summary & Community Trade Idea Sharing - Newser
Is Health Catalyst Inc. showing signs of accumulationStock Surge & Free Technical Confirmation Trade Alerts - Newser
What technical models suggest about Health Catalyst Inc.’s comeback - Newser
Health Catalyst extends slide as Citi adds to downgrades after Q2 miss - MSN
Health Catalyst Inc. Recovery Hinges on Volume Breakout2025 Momentum Check & Daily Volume Surge Trade Alerts - metrotimes.co.kr
Applying sector rotation models to Health Catalyst Inc.2025 Investor Takeaways & Safe Entry Momentum Tips - Newser
Health Catalyst (NASDAQ:HCAT) vs. Bullfrog AI (NASDAQ:BFRG) Critical Contrast - Defense World
Stocks Fall Amid Inflation Concerns: C3.ai, Health Catalyst, Upstart, Semrush, and Flywire Under Pressure. - AInvest
C3.ai, Health Catalyst, Upstart, Semrush, and Flywire Shares Are Falling, What You Need To Know - TradingView
5 Revealing Analyst Questions From Health Catalyst’s Q2 Earnings Call - Yahoo Finance
Is Health Catalyst Inc. a Top Dividend Stock to Watch in 2025Weekly Risk Summary & Free Expert Approved Momentum Trade Ideas - Newser
nCino, C3.ai, Five9, Health Catalyst, and RingCentral Shares Are Soaring, What You Need To Know - TradingView
Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price - simplywall.st
Wells Fargo & Company Has Lowered Expectations for Health Catalyst (NASDAQ:HCAT) Stock Price - Defense World
C3.ai, Health Catalyst, Wix, Jamf, and ON24 Shares Are Soaring, What You Need To Know - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Q2 2025 Earnings Call Transcript - Insider Monkey
Tick level data insight on Health Catalyst Inc. volatilityDownside Control Plan With Support Analysis - Newser
Will Health Catalyst Inc. Hold Gains Into CloseTrade Ready Stock Watch for Short Term Published - beatles.ru
5 Analysts Assess Health Catalyst: What You Need To Know - 富途牛牛
Health Catalyst stock slides as Citi downgrades (HCAT:NASDAQ) - Seeking Alpha
Health Catalyst Q2 2025 Results: Revenue On Target, Outlook WeakNews and Statistics - IndexBox
Wells Fargo lowers Health Catalyst PT to $6 from $10. - AInvest
HCAT Q2 Deep Dive: Medicaid Cuts Pressure Guidance, Profitability Initiatives Take Center Stage - TradingView
Citigroup Downgrades Health Catalyst to Neutral From Buy, Adjusts Price Target to $3.50 From $6.50 - MarketScreener
Health Catalyst stock drops as Wells Fargo cuts price target on client shifts - Investing.com India
Health Catalyst (NASDAQ:HCAT) Lowered to Neutral Rating by Citigroup - Defense World
Predicting Health Catalyst Inc. trend using moving averagesReal-Time AI Generated Market Forecast - Newser
Health Catalyst Inc. Stock Flags Risk Zone in Volatility IndexExpert Verified Stock Trade Ideas Backed by Data - beatles.ru
Wells Fargo Raises PT on Health Catalyst, Inc. (HCAT); Maintains ‘Buy’ Rating - MSN
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $4.50 - Defense World
Citigroup Downgrades Health Catalyst (NASDAQ:HCAT) to Neutral - Defense World
Slammed 30% Health Catalyst, Inc. (NASDAQ:HCAT) Screens Well Here But There Might Be A Catch - 富途牛牛
Health Catalyst Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
How Resilient Is Health Catalyst Inc. Stock During Economic DownturnsFree Early Entry Tips With Low Risk Zone - Newser
Cantor Fitzgerald Downgrades Health Catalyst (HCAT) to "Neutral," Cuts Price Target by 55.56% - AInvest
Citigroup Downgrades Health Catalyst to Neutral with New PT of $3.5. - AInvest
Health Catalyst Shares Fall After 2025 Revenue Guidance Cut, CEO to Step Down in June 2026 - 富途牛牛
Health Catalyst (HCAT): Navigating Medicaid Cuts and Strategic Restructuring to Unlock Long-Term Value - AInvest
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates - NewsBreak: Local News & Alerts
Health Catalyst CEO Retirement Announcement - The Globe and Mail
Health Catalyst HCAT Stock Drops 21.5% on Weak Revenue GuidanceNews and Statistics - IndexBox
Why Health Catalyst (HCAT) Stock Is Down Today - TradingView
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):